The Feinstein Institutes for Medical Research, the global scientific home of bioelectronic medicine, has been awarded a five-year grant totaling more than $3.7 million from the National Institutes of Health’s (NIH) National Institute of General Medical Sciences (NIGMS) to support research in the molecular basis of bioelectronic medicine. Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes, is the principal investigator leading the research.

Bioelectronic medicine explores the use of electronic devices to treat disease and injury through the body’s nervous system instead of pharmaceuticals. It combines molecular medicine, neuroscience and bioengineering. The goal of bioelectronic medicine is to identify neural targets that can be selectively activated or inhibited when needed and that, in turn, control the function of specific organs… Continue reading.